HitGen to collaborate with HHMI, Duke

By The Science Advisory Board staff writers

March 18, 2022 -- China's HitGen has entered a research collaboration agreement with the Howard Hughes Medical Institute (HHMI) and Duke University over the use of the company's OpenDEL DNA-encoded library (DEL).

Under the agreement, HHMI and Duke will use OpenDEL to perform selections against G-protein-coupled receptor targets. OpenDEL is an affordable self-service drug discovery DEL platform for startups, biotechs, and academic researchers.

The effort will be headed by 2012 Nobel Prize in Chemistry awardee Dr. Robert Lefkowitz, a professor of medicine and biochemistry and chemistry at Duke and a principal investigator at HHMI, and Dr. Howard Rockman, a professor of cardiology and medicine and cell biology at Duke.

Copyright © 2022 scienceboard.net

Microscopy and Microanalysis Meeting
July 31 - August 4
Portland, Oregon United States
Glasgow International Health Festival
August 24-27
Glasgow, Glasgow City United Kingdom
Pharma Competitive Intelligence Conference and Exhibition
September 21-22
Newark, New Jersey United States
BioProcess International (BPI) Conference
September 27-30
Boston, Massachusetts United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter